Advanced PSA Kinetics and Next-Generation PSMA-PET/CT: Navigating Biochemical Recurrence with Precision Localization
Biochemical recurrence (BCR)—a rising prostate-specific antigen (PSA) following definitive therapy—is a pivotal clinical crossroad in prostate cancer management. Whether detected…
Read More →
Managing High-Risk and Oligometastatic Prostate Cancer: Extended Pelvic Lymphadenectomy Combined with Multimodal Therapy
For decades, high-risk localized and oligometastatic prostate cancer were considered beyond the scope of primary surgical intervention. Patients presenting with…
Read More →
212-365-5000